Yifan F. Zhan
792 Elizabeth St
Melbourne, VIC 3000, Australia
Melbourne, VIC 3000, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
Efficacy and Safety of Recibokibart, an Interleukin-36 Receptor Antibody, in Generalized Pustular Psoriasis: A Phase 2 Randomized Trial.
Journal: The British journal of dermatology
Published: May 21, 2026
A Novel Phenolic Resin Aerogel Modified by SiO2-ZrO2 for Efficient Thermal Protection and Insulation.
Journal: Gels (Basel, Switzerland)
Published: November 20, 2025
Enhancing anti-tumor immunity through co-blocking PD-L1 and TIGIT by facilitating tumor-directed responses and additional VEGF inhibition.
Journal: Frontiers in immunology
Published: November 14, 2025
Foam-formed aramid aerogels reinforced by nanocellulose: distinct roles of bacterial and carboxylated cellulose nanofibers in tailoring strength and thermal insulation.
Journal: Journal of colloid and interface science
Published: October 23, 2025
Enhancing the treatment potential of IL-17 antagonism in lupus nephritis: finding the right partner.
Enhancing the treatment potential of IL-17 antagonism in lupus nephritis: finding the right partner.
Journal: Frontiers in immunology
Published: April 24, 2025
Enhancing quartz fiber dispersibility and wettability with bacterial cellulose for high-performance quartz paper.
Journal: Carbohydrate polymers
Published: January 01, 2025
Recibokibart, an anti-IL-36 receptor monoclonal antibody, for treating generalized pustular psoriasis: Phase 1b trial.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: October 05, 2024
Inhibition of P21-activated kinases 1 and 4 synergistically suppresses the growth of pancreatic cancer by stimulating anti-tumour immunity.
Journal: Cell communication and signaling : CCS
Published: February 21, 2024
Correction: Iguratimod attenuated fbrosis in systemic sclerosis via targeting early growth response 1 expression.
Journal: Arthritis research & therapy
Published: January 23, 2024
IL-36 antagonism blunts the proliferation and migration of oral squamous cell carcinoma cells.
Journal: Cellular signalling
Published: December 07, 2023
Last Updated: 09/26/2026